213 related articles for article (PubMed ID: 20594188)
1. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
[TBL] [Abstract][Full Text] [Related]
2. Differences in c-Jun N-terminal kinase recognition and phosphorylation of closely related stathmin-family members.
Yip YY; Yeap YY; Bogoyevitch MA; Ng DC
Biochem Biophys Res Commun; 2014 Mar; 446(1):248-54. PubMed ID: 24589734
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Lafarge S; Sylvain V; Ferrara M; Bignon YJ
Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
[TBL] [Abstract][Full Text] [Related]
5. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
7. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes.
Santibañez JF
FEBS Lett; 2006 Oct; 580(22):5385-91. PubMed ID: 16989819
[TBL] [Abstract][Full Text] [Related]
8. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine 170 is dispensable for c-Jun turnover.
Xie M; Sabapathy K
Cell Signal; 2010 Feb; 22(2):330-7. PubMed ID: 19818398
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.
Behrens A; Sibilia M; Wagner EF
Nat Genet; 1999 Mar; 21(3):326-9. PubMed ID: 10080190
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite.
Li Y; Shen L; Xu H; Pang Y; Xu Y; Ling M; Zhou J; Wang X; Liu Q
Toxicol Lett; 2011 Oct; 206(2):113-20. PubMed ID: 21726611
[TBL] [Abstract][Full Text] [Related]
12. Suppression of p53-dependent senescence by the JNK signal transduction pathway.
Das M; Jiang F; Sluss HK; Zhang C; Shokat KM; Flavell RA; Davis RJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15759-64. PubMed ID: 17893331
[TBL] [Abstract][Full Text] [Related]
13. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
Karin M; Gallagher E
IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor c-Jun activation represses mdr-1 gene expression.
Miao ZH; Ding J
Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
[TBL] [Abstract][Full Text] [Related]
15. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation through regulating cell cycle progression.
Zhang D; Li J; Song L; Ouyang W; Gao J; Huang C
Mol Cancer Res; 2008 Jan; 6(1):165-74. PubMed ID: 18234971
[TBL] [Abstract][Full Text] [Related]
16. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1.
Yao K; Cho YY; Bode AM; Vummenthala A; Park JG; Liu K; Pang YP; Dong Z
FEBS Lett; 2009 Jul; 583(13):2208-12. PubMed ID: 19527717
[TBL] [Abstract][Full Text] [Related]
17. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
[TBL] [Abstract][Full Text] [Related]
20. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes.
Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E
J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
